Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and naphthoquinones

lysyl-aspartyl-glutamyl-leucine has been researched along with naphthoquinones in 1 studies

Compound Research Comparison

Studies
(lysyl-aspartyl-glutamyl-leucine)
Trials
(lysyl-aspartyl-glutamyl-leucine)
Recent Studies (post-2010)
(lysyl-aspartyl-glutamyl-leucine)
Studies
(naphthoquinones)
Trials
(naphthoquinones)
Recent Studies (post-2010) (naphthoquinones)
1210227,1101492,923

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Y; Lv, X; Sun, A; Tao, X; Wei, D; Xu, R; Zhang, J1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and naphthoquinones

ArticleYear
TAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells.
    Oncotarget, 2016, Jun-14, Volume: 7, Issue:24

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Gene Products, tat; Heterografts; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Interleukins; Mice; Mice, Nude; Naphthoquinones; Oligopeptides; Protein Sorting Signals; Recombinant Fusion Proteins; Survivin; Xenograft Model Antitumor Assays

2016